47.97
前日終値:
$48.21
開ける:
$48.19
24時間の取引高:
2.59M
Relative Volume:
1.01
時価総額:
$7.51B
収益:
$1.22B
当期純損益:
$81.07M
株価収益率:
93.31
EPS:
0.5141
ネットキャッシュフロー:
$223.02M
1週間 パフォーマンス:
+5.39%
1か月 パフォーマンス:
-11.56%
6か月 パフォーマンス:
-25.85%
1年 パフォーマンス:
+2.44%
Bio Techne Corp Stock (TECH) Company Profile
Compare TECH vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
TECH
Bio Techne Corp
|
47.97 | 7.55B | 1.22B | 81.07M | 223.02M | 0.5141 |
|
VRTX
Vertex Pharmaceuticals Inc
|
435.92 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.42 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
808.61 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
|
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Bio Techne Corp Stock (TECH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-03 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-08-21 | アップグレード | Citigroup | Neutral → Buy |
| 2025-07-22 | 再開されました | Stephens | Overweight |
| 2025-07-09 | 開始されました | TD Cowen | Buy |
| 2025-05-30 | 開始されました | Wells Fargo | Overweight |
| 2025-04-09 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-03-18 | 開始されました | Evercore ISI | Outperform |
| 2025-02-19 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-05-22 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-02-08 | 開始されました | Scotiabank | Sector Outperform |
| 2024-02-02 | ダウングレード | Stifel | Buy → Hold |
| 2023-12-07 | 開始されました | UBS | Buy |
| 2023-08-28 | 開始されました | William Blair | Outperform |
| 2023-01-10 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2022-12-14 | 開始されました | Deutsche Bank | Buy |
| 2022-12-12 | アップグレード | Citigroup | Neutral → Buy |
| 2022-12-07 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-04-25 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2021-09-15 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-08 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2021-02-23 | アップグレード | Stifel | Hold → Buy |
| 2021-01-25 | 繰り返されました | The Benchmark Company | Buy |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 開始されました | Atlantic Equities | Overweight |
| 2020-07-15 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2020-05-27 | ダウングレード | Stifel | Buy → Hold |
| 2020-05-14 | 開始されました | The Benchmark Company | Buy |
| 2020-01-08 | 再開されました | Stephens | Overweight |
| 2020-01-08 | 開始されました | Wells Fargo | Equal Weight |
| 2020-01-07 | 開始されました | Citigroup | Neutral |
| 2019-11-15 | 開始されました | Stifel | Buy |
| 2019-07-02 | アップグレード | Janney | Neutral → Buy |
| 2019-01-14 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2018-10-31 | ダウングレード | Craig Hallum | Buy → Hold |
| 2018-10-17 | 開始されました | Goldman | Neutral |
| 2018-06-15 | 開始されました | Argus | Buy |
| 2017-07-13 | 開始されました | Wells Fargo | Market Perform |
| 2017-02-09 | 開始されました | Citigroup | Buy |
| 2017-01-18 | 開始されました | Deutsche Bank | Buy |
| 2016-11-10 | 再開されました | Leerink Partners | Outperform |
| 2015-01-21 | 繰り返されました | Robert W. Baird | Outperform |
| 2013-09-20 | アップグレード | Robert W. Baird | Neutral → Outperform |
すべてを表示
Bio Techne Corp (TECH) 最新ニュース
Bio-Techne stock hits 52-week low at 46.04 USD By Investing.com - Investing.com Nigeria
Are Wall Street Analysts Bullish on Bio-Techne Stock? - inkl
Bio-Techne Corp (TECH) Stock Analysis: An Investor's Look At 27% Potential Upside - DirectorsTalk Interviews
Bio-Techne Corp. stock outperforms competitors on strong trading day - MarketWatch
Bio-Techne Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Bio-Techne Corp (TECH) Stock Analysis: Unlocking a 41.84% Upside Potential in Healthcare Innovation - DirectorsTalk Interviews
The 5 Most Interesting Analyst Questions From Bio-Techne’s Q1 Earnings Call - Yahoo Finance
Bio-Techne stock hits 52-week low at 44.09 USD - Investing.com India
Bio-Techne stock hits 52-week low at 44.09 USD By Investing.com - Investing.com Australia
Bio-Techne Corp. stock underperforms Friday when compared to competitors - MarketWatch
RBC Capital Mkts resumed coverage on Bio-Techne with a new price target - Quantisnow
Bio-Techne (TECH) Coverage Reinitiated with Positive Outlook - GuruFocus
RBC Capital assumes Bio-Techne stock coverage with outperform rating By Investing.com - Investing.com Australia
RBC Capital assumes Bio-Techne stock coverage with outperform rating - Investing.com UK
Baron Asset Fund Sold Bio-Techne Corporation (TECH) Due to Concerns Over Potential Impact of AI - Yahoo Finance
Bio-Techne Corp. stock underperforms Wednesday when compared to competitors - MSN
There May Be Some Bright Spots In Bio-Techne's (NASDAQ:TECH) Earnings - Yahoo Finance
TECH Stock Price, Quote & Chart | BIO-TECHNE CORP (NASDAQ:TECH) - ChartMill
Bio-Techne (TECH) director’s linked account exercises options and sells 6,636 shares - Stock Titan
Earnings call transcript: Bio-Techne Q3 2026 misses EPS and revenue targets By Investing.com - Investing.com South Africa
Earnings call transcript: Bio-Techne Q3 2026 misses EPS and revenue targets - Investing.com Nigeria
How Bio-Techne is bridging cancer research, spatial biology, and diagnostics - SelectScience
Bio-Techne Corp. stock underperforms Monday when compared to competitors - MarketWatch
Nicholas Company Inc. Acquires 23,785 Shares of Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp (TECH) Stock Analysis: Exploring a 29.52% Potential Upside Amidst Market Volatility - DirectorsTalk Interviews
Bio-Techne(TECH) Stock Options Chain | Quotes & News - Moomoo
BIO-TECHNE CORPORATION CMNRo Khanna Congressional Trade on Apr. 13, 2026 - Quiver Quantitative
Responsive Playbooks and the TECH Inflection - Stock Traders Daily
Principal Financial Group Inc. Has $41.37 Million Stock Position in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp (NASDAQ:TECH) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
TECH (TECH) Form 144 shows planned option-exercise sales, prior sale by Molho - Stock Titan
Earnings call transcript: Bio-Techne Q3 2026 results show strategic focus - Investing.com UK
Earnings call transcript: Bio-Techne Q3 2026 results show strategic focus By Investing.com - Investing.com South Africa
Rep. April McClain Delaney Sells Bio-Techne Corp (NASDAQ:TECH) Shares - MarketBeat
April McClain Delaney Makes Significant Trades in Bio-Techne Corp, C.H. Robinson Worldwide, and Transdigm Group - Investing.com UK
Evercore Maintains Bio-Techne(TECH.US) With Hold Rating, Cuts Target Price to $50 - Moomoo
TECH Maintained by Evercore ISI Group -- Price Target Lowered to $50 - GuruFocus
CFO at Bio-Techne (TECH) exercises 62,000 options and settles taxes in shares - Stock Titan
Bio-Techne (TECH) SVP exercises 8,400 options, 7,055 shares withheld for taxes - Stock Titan
Bio-Techne (TECH) CEO exercises options; shares withheld for taxes - Stock Titan
Citigroup Issues Pessimistic Forecast for Bio-Techne (NASDAQ:TECH) Stock Price - MarketBeat
Bio Techne Corp (TECH) 財務データ
収益
当期純利益
現金流量
EPS
Bio Techne Corp (TECH) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Herr Amy E. | Director |
May 08 '26 |
Sale |
48.28 |
6,636 |
320,386 |
200 |
大文字化:
|
ボリューム (24 時間):